Sign up for the premium plan and unlock all options
After purchasing the premium plan, you will unlock all information about drug prices and their availability.
Search
Listing 560421 - 560440 out of 561067 entries
| Country | ATC | Drug name | Drug form, strength, package | Price level | Price in € | Price in local currency | Therapeutic areas | Manufacturer / Importer |
|---|---|---|---|---|---|---|---|---|
| USA | (L01EX11) quizartinib | VANFLYTA 26.5MG TAB | 28 | Ex-factory price without vat |
$0-0 |
$0-0 |
Leukemia, Myeloid | DaiichiSankyo,Inc. |
| USA | (L01EX11) quizartinib | VANFLYTA 26.5MG TAB | 14 | Ex-factory price without vat |
$0-0 |
$0-0 |
Leukemia, Myeloid | DaiichiSankyo,Inc. |
| USA | (L01EX13) gilteritinib (adm: O) | XOSPATA 40MG TAB | 90 | Ex-factory price without vat |
$0-0 |
$0-0 |
Leukemia, Myeloid, Acute | AstellasPharmaU.S.,Inc. |
| USA | (L01EX15) pexidartinib (adm: O) | TURALIO 125MG CAP,ORAL | 120 | Ex-factory price without vat |
$0-0 |
$0-0 |
n/a | DaiichiSankyo,Inc. |
| USA | (L01EX15) pexidartinib (adm: O) | TURALIO 125MG CAP,ORAL | 120 | Ex-factory price without vat |
$0-0 |
$0-0 |
n/a | DaiichiSankyo,Inc. |
| USA | (L01FD04) trastuzumab deruxtecan (adm: P) | ENHERTU 100MG | 1 | Ex-factory price without vat |
$0-0 |
$0-0 |
Breast Neoplasms | DaiichiSankyo,Inc. |
| USA | (L01FD04) trastuzumab deruxtecan (adm: P) | ENHERTU 100MG | 1 | Ex-factory price without vat |
$0-0 |
$0-0 |
Breast Neoplasms | DaiichiSankyo,Inc. |
| USA | (L01FX) other monoclonal antibodies and antibody drug conjugates | YARTEMLEA 185MG/ML INJ,SOLN | 2ML | Ex-factory price without vat |
$0-0 |
$0-0 |
n/a | OmerosCorporation |
| USA | (L01FX15) belantamab mafodotin | BLENREP 70MG/VIAL INJ | 1 | Ex-factory price without vat |
$0-0 |
$0-0 |
Multiple Myeloma | GlaxoSmithKline |
| USA | (L01FX15) belantamab mafodotin | BLENREP 70MG/VIAL INJ | 1 | Ex-factory price without vat |
$0-0 |
$0-0 |
Multiple Myeloma | GlaxoSmithKline |
| USA | (L01FX18) amivantamab | RYBREVANT FASPRO 2400MG | 15ML | Ex-factory price without vat |
$0-0 |
$0-0 |
Carcinoma, Non-Small-Cell Lung | J&JHealthCareSystemsonbehalfofJanssenBiotechInc. |
| USA | (L01FX18) amivantamab | RYBREVANT FASPRO 2400MG | 15ML | Ex-factory price without vat |
$0-0 |
$0-0 |
Carcinoma, Non-Small-Cell Lung | J&JHealthCareSystemsonbehalfofJanssenBiotechInc. |
| USA | (L01FX18) amivantamab | RYBREVANT FASPRO 3520MG | 22ML | Ex-factory price without vat |
$0-0 |
$0-0 |
Carcinoma, Non-Small-Cell Lung | J&JHealthCareSystemsonbehalfofJanssenBiotechInc. |
| USA | (L01FX18) amivantamab | RYBREVANT FASPRO 3520MG | 22ML | Ex-factory price without vat |
$0-0 |
$0-0 |
Carcinoma, Non-Small-Cell Lung | J&JHealthCareSystemsonbehalfofJanssenBiotechInc. |
| USA | (L01FX22) loncastuximab tesirine | ZYNLONTA 10MG/VIAL INJ | 1 | Ex-factory price without vat |
$0-0 |
$0-0 |
Lymphoma, Large B-Cell, Diffuse;Lymphoma, B-Cell | ADCTherapeuticsAmerica,Inc. |
| USA | (L01FX25) mosunetuzumab | LUNSUMIO VELO 45MG/ML INJ,SOLN | 1ML | Ex-factory price without vat |
$0-0 |
$0-0 |
Lymphoma, Follicular | GenentechUSA,Inc. |
| USA | (L01FX25) mosunetuzumab | LUNSUMIO VELO 45MG/ML INJ,SOLN | 1ML | Ex-factory price without vat |
$0-0 |
$0-0 |
Lymphoma, Follicular | GenentechUSA,Inc. |
| USA | (L01FX25) mosunetuzumab | LUNSUMIO VELO 10MG/ML INJ,SOLN | 0.5ML | Ex-factory price without vat |
$0-0 |
$0-0 |
Lymphoma, Follicular | GenentechUSA,Inc. |
| USA | (L01FX25) mosunetuzumab | LUNSUMIO VELO 10MG/ML INJ,SOLN | 0.5ML | Ex-factory price without vat |
$0-0 |
$0-0 |
Lymphoma, Follicular | GenentechUSA,Inc. |
| USA | (L01FX26) mirvetuximab soravtansine | ELAHERE 100MG INJ | 20ML | Ex-factory price without vat |
$0-0 |
$0-0 |
Ovarian Neoplasms;Fallopian Tube Neoplasms;Peritoneal Neoplasms | AbbvieUSLLC |
Pages
